Aldosterone synergistically modulates cardiac hypertrophy with endothelin-1 via reinforcement of the JNK pathway, providing mechanistic insight into cardiac remodeling.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for aldosterone-endothelin synergy in hypertrophy; leaves open clinical relevance pending human studies.
Aldosterone is thought to regulate cardiac work independently of sodium retention, though the mechanisms remain to be known. In the present study, we have demonstrated that aldosterone reinforces endothelin-mediated cardiac hypertrophy with the increase in cell surface area and upregulation of the transcripts characteristic of hypertrophy. We have also shown that aldosterone augments c-Jun N-terminal kinase activation induced by endothelin-1. Taken together, it is suggested that aldosterone modulates cardiac hypertrophy, at least partially, synergistically with extracellular signals that have been shown to be involved in cardiac remodeling.
No takes yet. Share an insight, caveat, or question.
Oshima et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: